AKT1 and rheumatoid arthritis: Chemerin regulates inflammatory responses through activation of MAPK and PI3K/Akt pathways leading to enhanced production of inflammatory mediators by RA FLSs [58] and NF-κB activation [59], in addition to its chemoattractant properties enhancing immune cells infiltration into the RA synovium [16].